Bicycle Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Net Income	-168.16	-180.66	-112.72	-66.82	-51.01	-30.61	Upgrade
Depreciation & Amortization	6.65	6.55	3.69	1.41	1.28	0.96	Upgrade
Share-Based Compensation	32.72	32.48	26.78	12.08	6.51	3.08	Upgrade
Other Operating Activities	43.71	81.01	-3.86	38.53	25.43	-2.05	Upgrade
Operating Cash Flow	-85.09	-60.63	-86.11	-14.79	-17.79	-28.61	Upgrade
Capital Expenditures	-0.84	-2.93	-18.99	-2.03	-1.2	-1.56	Upgrade
Investing Cash Flow	-0.84	-2.93	-18.99	-2.03	-1.2	-1.56	Upgrade
Share Issuance / Repurchase	249.18	250.03	6.69	305.73	48.42	57.11	Upgrade
Debt Issued / Paid	0	0	0	15	14.43	0	Upgrade
Other Financing Activities	-	-	-	-	-	1.33	Upgrade
Financing Cash Flow	249.18	250.03	6.69	320.73	62.84	58.44	Upgrade
Exchange Rate Effect	0.48	1.35	-1.12	-1.21	0.02	0.47	Upgrade
Net Cash Flow	163.73	187.82	-99.53	302.69	43.87	28.74	Upgrade
Free Cash Flow	-85.93	-63.56	-105.1	-16.82	-18.99	-30.17	Upgrade
Free Cash Flow Margin	-206.51%	-235.61%	-726.67%	-143.83%	-182.76%	-218.59%	Upgrade
Free Cash Flow Per Share	-2.02	-1.79	-3.54	-0.67	-0.99	-2.73	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).